MOR106 single ascending doses, intravenous
MOR106-CL-101
Phase 1 small_molecule completed
Quick answer
MOR106 single ascending doses, intravenous for Healthy is a Phase 1 program (small_molecule) at Lakefront Biotherapeutics NV with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lakefront Biotherapeutics NV
- Indication
- Healthy
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed